tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PYXS Stock Latest News

Pyxis Oncology initiated with a Buy at Guggenheim
The FlyPyxis Oncology initiated with a Buy at Guggenheim
5d ago
PYXS
Pyxis Oncology initiated with a Buy at Guggenheim
PremiumThe Fly
Pyxis Oncology initiated with a Buy at Guggenheim
5d ago
PYXS
Optimistic Buy Rating for Pyxis Oncology Driven by Promising MICVO Developments and Strategic Merck Collaboration
PremiumRatings
Optimistic Buy Rating for Pyxis Oncology Driven by Promising MICVO Developments and Strategic Merck Collaboration
20d ago
PYXS
Buy Rating for Pyxis Oncology: Promising Prospects for Micvo and Strong Financial Position
PremiumRatings
Buy Rating for Pyxis Oncology: Promising Prospects for Micvo and Strong Financial Position
24d ago
PYXS
Pyxis Oncology Reports Q2 2025 Financial Results
PremiumCompany Announcements
Pyxis Oncology Reports Q2 2025 Financial Results
25d ago
PYXS
Pyxis Oncology reports Q2 EPS (30c), consensus (35c)
PremiumThe FlyPyxis Oncology reports Q2 EPS (30c), consensus (35c)
25d ago
PYXS
Pyxis Oncology Updates Phase 1 Trial Enrollment
Premium
Company Announcements
Pyxis Oncology Updates Phase 1 Trial Enrollment
1M ago
8K
PYXS
Crescent Biopharma appoints Jan Pinkas as CSO
Premium
The Fly
Crescent Biopharma appoints Jan Pinkas as CSO
2M ago
CBIO
PYXS
Pyxis Oncology Appoints New Principal Financial Officer
PremiumCompany Announcements
Pyxis Oncology Appoints New Principal Financial Officer
2M ago
8K
PYXS
Pyxis Oncology Elects New Directors at Annual Meeting
PremiumCompany Announcements
Pyxis Oncology Elects New Directors at Annual Meeting
3M ago
8K
PYXS
Pyxis Oncology Reports Increased Losses Amidst Ongoing R&D Investments
PremiumCompany Announcements
Pyxis Oncology Reports Increased Losses Amidst Ongoing R&D Investments
3M ago
PYXS
Promising Developments and Risk-Reward Profile Justify Buy Rating for Pyxis Oncology
PremiumRatings
Promising Developments and Risk-Reward Profile Justify Buy Rating for Pyxis Oncology
4M ago
PYXS
Buy Rating for Pyxis Oncology Driven by Promising Preclinical Data and Upcoming Clinical Updates
PremiumRatingsBuy Rating for Pyxis Oncology Driven by Promising Preclinical Data and Upcoming Clinical Updates
4M ago
PYXS
Pyxis Oncology Reports Q1 Loss and Business Update
Premium
Company Announcements
Pyxis Oncology Reports Q1 Loss and Business Update
4M ago
8K
PYXS
Pyxis Oncology reports Q1 EPS (35c), consensus (30c)
Premium
The Fly
Pyxis Oncology reports Q1 EPS (35c), consensus (30c)
4M ago
PYXS
PYXS Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PYXS Upcoming Earnings Report: What to Expect?
4M ago
PYXS
Pyxis Oncology Highlights Strategic Focus on Lead Candidate
PremiumCompany Announcements
Pyxis Oncology Highlights Strategic Focus on Lead Candidate
6M ago
8K
PYXS
Optimistic Buy Rating for Pyxis Oncology Amid Strategic Focus and Promising Drug Developments
PremiumRatings
Optimistic Buy Rating for Pyxis Oncology Amid Strategic Focus and Promising Drug Developments
6M ago
PYXS
Promising Prospects for Pyxis Oncology: Buy Rating Affirmed on Strong Clinical Profile and Strategic Focus
PremiumRatings
Promising Prospects for Pyxis Oncology: Buy Rating Affirmed on Strong Clinical Profile and Strategic Focus
6M ago
PYXS
Promising Clinical Developments and Strategic Focus Drive Buy Rating for Pyxis Oncology
PremiumRatingsPromising Clinical Developments and Strategic Focus Drive Buy Rating for Pyxis Oncology
6M ago
PYXS
Pyxis Oncology Advances Cancer Therapeutics with MICVO
Premium
Company Announcements
Pyxis Oncology Advances Cancer Therapeutics with MICVO
6M ago
PYXS
Pyxis Oncology Announces CMO Resignation and New Trials
Premium
Company Announcements
Pyxis Oncology Announces CMO Resignation and New Trials
6M ago
8K
PYXS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >